Skip to main content

Department of Pediatrics Archives

Trevathan named director for the Vanderbilt Institute for Global Health

Nov. 20, 2017—Edwin Trevathan, MD, MPH, a pediatric neurologist and epidemiologist who has previously held prominent university leadership positions at Washington University in St. Louis (director of Pediatric Neurology), St. Louis University (dean, School of Public Health) and Baylor University (Provost and Executive Vice President) as well as at the U.S. Centers for Disease Control and Prevention (CDC), has been appointed director of the Vanderbilt Institute for Global Health (VIGH), effective Jan. 1, 2018.

Read more


Boosting sarcoma cell death

Oct. 4, 2017—A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.

Read more


Delirium, benzos and the pediatric ICU

Oct. 2, 2017—With other risk factors held equal, children who received a benzodiazepine sedative drug were nearly three times more likely to experience delirium – confused thought – the following day.

Read more


Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs

Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.

Read more


Address highlights Pediatrics’ people, progress, growth

Sep. 7, 2017—Steven Webber, MBChB, MRCP, delivered the annual State of the Department of Pediatrics address on Tuesday, with growth and quality improvement serving as recurring themes along with a focus on the department’s four mission areas — discovery, clinical care, education and advocacy, service and community partnerships.

Read more


Doris Duke Foundation lauds Van Driest’s research

Jul. 27, 2017—Sara Van Driest, M.D., Ph.D., who is developing methods for precision dosing of pediatric medications at Vanderbilt University Medical Center (VUMC), has received a 2017 Clinical Scientist Development Award from the Doris Duke Charitable Foundation.

Read more


Bile acids, microbiota and colon cancer

Jul. 5, 2017—Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis.

Read more


Team investigates antiviral that inhibits SARS, MERS

Jun. 29, 2017—A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.

Read more


Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children

Jun. 22, 2017—In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious.

Read more


Patrick honored for neonatal abstinence syndrome research

Jun. 15, 2017—Stephen W. Patrick, M.D., MPH, MS, has been chosen to receive the Nemours Child Health Services Research Award, recognizing his work surrounding neonatal abstinence syndrome, a drug withdrawal syndrome experienced by infants exposed to opioids while in utero.

Read more


New screening model quickly spots acute kidney injury

Jun. 8, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have developed a screening tool intended to more quickly identify patients with acute kidney injury (AKI).

Read more


Hepatitis C infections among pregnant women increasing

May. 11, 2017—Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country’s increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.

Read more


Page 3 of 1312345678...Last »

Upcoming Events

MORE EVENTS »